Zacks Investment Research lowered shares of CynergisTek (NYSEAMERICAN:CTEK) from a hold rating to a sell rating in a research report report published on Wednesday, December 6th.
According to Zacks, “AUXILIO, Inc. provides Managed Print Services (MPS) for the health care industry. The Company provides management and monitoring of vital business and clinical processes in copy, print, fax and scan infrastructures. It operates as a vendor independent company and offers monitoring, management, and contract negotiation; change management and end-user training programs; utilization management; financial reporting; workflow efficiency management; information systems integration, connectivity, and image migration strategies; and strategy execution working with the customer to execute a long-term image management strategy. The Company sells and services automated office equipment, including digital and color copiers, printers, facsimile machines, scanners, and multi-function equipment. AUXILIO, Inc. is headquartered in Mission Viejo, California. “
Shares of CynergisTek (CTEK) traded up $0.04 during mid-day trading on Wednesday, reaching $4.05. The company had a trading volume of 24,901 shares, compared to its average volume of 27,462. The stock has a market cap of $38.10, a price-to-earnings ratio of 6.86 and a beta of 0.67. CynergisTek has a one year low of $2.36 and a one year high of $6.72.
Cynergistek, Inc provides outsourced document management services and IT security consulting services primarily to the healthcare industry in the United States. It offers workflow solutions; and creates manageable, dependable print management programs by managing the back-office processes of hospital clients.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CynergisTek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CynergisTek and related companies with MarketBeat.com's FREE daily email newsletter.